HUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM. Version

Similar documents
Title: Revision of the Surveillance Case Definition for HIV Infection and AIDS Among children age > 18 months but < 13 years

HEPATITIS B NON-IMMEDIATE NOTIFICATION EPIDEMIOLOGY PROGRAM

10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission

Measure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy

QUARTERLY HIV/AIDS SURVEILLANCE REPORT


QUARTERLY AIDS SURVEILLANCE REPORT

Supplementary Online Content

medical monitoring: clinical monitoring and laboratory tests

Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016

Immunodeficiencies HIV/AIDS

Presented by: Melissa Egan, Regional Health Education Coordinator, CATIE Date: Tuesday October 8th, 2013, 1 2pm EST

HIV Update in Laboratory Testing. Patricia Slev, PhD, D(ABCC)

R EVISION OF CDC/WHO CASE DEFINITION FOR ACQUIRED IMMUNODEFICIENCY SYNDROME-(AIDS) :

OI prophylaxis When to start, when to stop. Eva Raphael, MD MPH Family and community medicine, pgy-2 University of California, San Francisco

NEW PATIENT REGISTRATION

Doctor, I Have Strep Throat. Nancy W Weber D.O. FACOEP FACEP MBA Sparrow/MSU Emergency Medicine Residency October 22, 2018

Defining AIDS. Defining AIDS HIV 3 DECADES LATER. Adversity reveals genius, prosperity conceals it. Horace

Mortality Rates Among People With HIV, Long on the Wane, Continue to Drop HIV Medicine Feb 2013

San Francisco AIDS Cases Reported Through December 31, 1998

The Italian AIDS Epidemic Supports The Chemical AIDS Theory. Daniele Mandrioli

Complicated viral infections

Chapter 22. Autoimmune and Immunodeficiency Diseases

STRATEGIES INFECTIONS

New HIV Tests and Algorithm: A change we can believe in

INTEGRATING HIV INTO PRIMARY CARE

HIV Testing Technology and the Latest Algorithm

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS

HIV Test Technologies, Best Practices, and New Algorithm. Jenny R. McFarlane DSHS HIV Prevention and Care Branch

Trends in molecular diagnostics

Cancer risk and prevention in persons living with HIV/AIDS (PLWHA) Robert Dubrow, MD, PhD Professor of Epidemiology Yale School of Public Health

San Francisco Department of Public Health. Level I Data Requirements (Applicable to All Agencies)

OUTCOME CODES FOR MACS STATUS FORM

Welcome to Carolinas CARE Partnership. HIV A to Z: 6/30/2015. Objectives. The Basics and Beyond. Introductions Pre-Test Expectations

Other Diagnostic Tests

patients with blood borne viruses Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled Document Lead:

958 HIV: The Initial Physician-Patient Encounter Mayo Clin Proc, September 2002, Vol 77 Table 1. Indications for HIV Screening* High-risk behaviors Mu

HIV Diagnostic Testing

Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems

Sexually Transmi/ed Diseases

Immunodeficiency. (2 of 2)

Clinical Manifestations of HIV

LOS ANGELES COUNTY DEPARTMENT OF HEALTH SERVICES HIV EPIDEMIOLOGY PROGRAM

List the steps in the fourth generation HIV screening algorithm Describe the relationship between rapid HIV antibody tests and the fourth generation

A Summary of Clinical Evidence

Diagnosing HIV Infection AMNERIS E. LUQUE, M.D. PROFESSOR OF MEDICINE/INFECTIOUS DISEASES MEDICAL DIRECTOR, PARKLAND HIV SERVICES

Adventures in Discordance- HIV Testing

Diagnostic Tests for HIV

SYPHILIS (Treponema pallidum) IMMEDIATE NOTIFICATION STD PROGRAM

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

HIV/AIDS 101. HIV Case Manager Portal. Current as of March 2014.

New Generation of Nucleic Acid Testing. Michele Owen, Ph.D Division of HIV/AIDS Prevention Centers for Disease Control & Prevention

HIV Transmission HASPI Medical Biology Lab 20

AIDS. urvival. Hepatitis C. Race/Ethnicity. Women. revalence. Morbidity TRENDS. Transgender MEN HAART. Men who have sex with men. Injection Drug Use

HIV-1 Genemer Detection Kit Ready to Use Amplification Kit for HIV-1 Specific DNA Fragment Analysis

HIV A 2017 Update Bill Rooney MD SCOR Global Life

Updates in HIV Medicine. Dr. Jacky Chan Associate Consultant Princess Margaret Hospital

The importance of cohort collaborations for guiding clinical management of individuals with HIV infection

Opportunities Created by Diagnostic HCV and HIV Nucleic Acid Tests

The Alphabet Soup of Viral Hepatitis Testing

2018 HIV and HCV Diagnostic Testing Survey

Case Definition and Lab Tests

Technical Bulletin No. 104b

HIV Serology Quality Assessment Program Summary for Panel HIVSER 2017Apr19

Chapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003

HIV Lecture. Anucha Apisarnthanarak, MD Division of Infectious Diseases Thammasart University Hospital

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a

CHIPS APPENDICES: VERSION 2.4

Amsterdam Cohort Studies among homosexual men and drug users

ACQUIRED IMMUNODEFICIENCY SYNDROME AND ITS OCULAR COMPLICATIONS

HIV Serology Quality Assessment Program Summary for Panel HIVS Oct22

The Human Immunodeficiency Virus and the Colon and Rectal Surgeon

RNA PCR, Proviral DNA and Emerging Trends in Infant HIV Diagnosis

APHL/CDC HIV Demonstration Project Demonstration Project for HIV Nucleic Acid Testing (NAT) Referral Updated: January 2018

Routine HIV Testing Community of Practice Session #2

HIV CME. Sarah Barbour, MD Orlando Health Infectious Disease Fellowship Program

Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease

Improving quality of services and retention in HIV care and treatment: Severely immunosuppressed package of care (SIPOC)

ARCHITECT HIV Ag/Ab Combo: Moving HIV Diagnostics Forward in the U.S.

Human Immunodeficiency Virus Serology

8/10/2017. HIV UPDATE 2017 David M Stein DO, FACOI

Immunologic Methods in Diagnosis of HIV Infection. Tehran Medical Sciences Branch, Islamic Azad

Human Immunodeficiency Virus-1 (HIV-1) Genemer. Primer Pair for amplification of HIV-1 Specific DNA Fragment

Can we treat our way out of the HIV epidemic?

Viruses. Poxviridae. DNA viruses: 6 families. Herpesviridae Adenoviridae. Hepadnaviridae Papovaviridae Parvoviridae

Medical monitoring: Clinical monitoring and laboratory tests

Overview of HIV Testing Practices and Technology

HIV- INFECTION WHO case definition for HIV infection 2007 Adults and children 18 months or older HIV infection is diagnosed based on:

LSOCA General Knowledge Assessment

HIV/AIDS Primer for Nurse Practitioners Nursing is Attending to Meaning. Bill Wade R.N June 21,2005.

Webinar. Cellular Medicine & HIV/AIDS. Fabrice Leu N.D

2. Clinical Manifestations (Pediatric HIV Infection)

HIV EPIDEMIOLOGY PROGRAM

Diagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know

Viral Hepatitis Diagnosis and Management

Index. B Biological factors, 2 Brain stem encephalitis, Burkitt s lymphoma, 83, 105

CMV. Inclusions predominantly in endothelial cells. Immunostaining greater sensitivity than H&E alone.

The Struggle with Infectious Disease. Lecture 6

Chapter 25 Notes Lesson 1

Transcription:

1 HUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM Event Name: Event Time Period: ADULT HIV 900 (AIDS.gov 12/31/2015) HIV Lifelong HIV (human immunodeficiency virus) is a retrovirus with two serologically and geographically distinct species: HIV- 1 and HIV-2. It is spread via person-to-person transmission through: sexual contact, the use of HIV-contaminated needles and syringes, vertical transmission from mother to infant, or the transfusion of infected blood or its components. If left untreated, HIV can progress to the disease AIDS (acquired immunodeficiency syndrome). Unlike some other viruses, the human body cannot get rid of HIV completely. HIV attacks the body s immune system, specifically the CD4 cells (T cells). If left untreated, HIV reduces the number of CD4 cells in the body, making the person more likely to get infections or infection-related cancers. These opportunistic infections or cancers take advantage of the weakened immune system and signal that the person has AIDS (the advanced stage of HIV infection). The incubation period is variable, although the time from infection to the development of detectable antibodies is generally less than one month. The time from HIV infection to diagnosis of AIDS, in the absence of antiretroviral treatment, has an observed range less than 1 year to 15 years or longer, with an average of about ten years from infection to an AIDS diagnosis. Positive HIV 1, Positive HIV 2, or Positive (Undifferentiated) HIV result from a differentiating immunoassay, Western Blot, IFA, or culture OR Positive/Detected Qualitative HIV NAT (DNA or RNA) OR Quantitative HIV NAT (detectable viral load assay) Probable Complete CRF received with MD confirmed diagnosis, no confirmatory lab Positive Ag/Ab screen, Positive EIA, Positive p24ag, undetectable viral load, or CD4 Revoked Inappropriately created case, not an MA case, cancer, CD4 only PEDIATRIC HIV- 900P <13 years old Probable Revoked *If case is less than 13 years old, alert the HIV liaison Two Positive HIV virologic test (HIV 1 NAT, HIV 1 p24, culture) results from 2 different specimens obtained on different dates Single Positive HIV virologic test (HIV 1 NAT, HIV 1 p24, culture) Positive Ab in <18 month olds) Inappropriately created case, not an MA case, cancer

2 ADULT AIDS - 950 (AIDS.gov 12/31/2015) AIDS stands for acquired immunodeficiency syndrome. AIDS is the advanced stage of HIV infection, and not everyone who has HIV advances to this stage. AIDS is the stage of infection that occurs when your immune system is compromised and you become vulnerable to opportunistic infections. When your CD4 cells falls below 200 cells per cubic millimeter of blood (200 cells/mm3), you are considered to have progressed to AIDS (rmal CD4 counts are between 500 and 1,600 cells/mm3). You can also be diagnosed with AIDS if you develop one or more opportunistic infections, regardless of your CD4 count. evidence of HIV and complete CRF received AND CD4 absolute count <200 (or in absence of CD4 absolute count, CD4 percent below 14%) AND/OR an opportunistic infection diagnosis Probable Complete CRF received with MD confirmed diagnosis, no confirmatory lab CD4 absolute count <200 (or in absence of CD4 absolute count, CD4 percent below 14%) Revoked Inappropriately created case, not an MA case, cancer, CD4 only PEDIATRIC AIDS 950P <13 years old Probable Revoked *If case is less than 13 years old, alert the HIV liaison See case classification for adult AIDS See case classification for adult AIDS See case classification for adult AIDS Inappropriately created case, not an MA case, cancer

Report Type Test Type Source Result Laboratory report HIV-1/2 Ab/Ag screen (4 th gen) Blood, serum, saliva Positive, Reactive 3 New event? Data Entry Select: HIV 1+2 Ab HIV1 p24 Ag: ACnc : Pt : Ser : Ord : EIA 56888-1 HIV-1/2 Ag/Ab screening HIV 1 Ab+Ag [Presence] in Serum 51866-2 HIV-1/2 Ag/Ab screening Laboratory report EIA, ELISA Blood, serum, saliva Positive Select: HIV 1+2 Ab [Presence]: ACnc : Pt : XXX : Ord 43010-8 HIV-1/2 IA (EIA or Other) HIV 1+O+2 Ab [Presence] : ACnc : Ser/Plas : Ord 48345-3 HIV-1/2 IA (EIA or Other) HIV 1 Ab [Units/volume] : ACnc : Pt : Ser : Qn : EIA 5220-9 HIV-1 IA (EIA or Other) HIV 1 Ab : ACnc : Pt : Body fld : QI : Ord 29327-4 HIV-1 IA (EIA or Other) HIV 2 Ab [Presence] : ACnc: Pt : Ser : QI : Ord : EIA 30361-0 HIV-2 IA (EIA or Other) Laboratory report HIV-1 p24 Antigen Blood, serum, saliva Positive Select: HIV 1 p24 Ag [Presence] : ACnc : Pt : CSF : Ord 49718-0 HIV-1 p24 Antigen HIV 1 P24 Ag : ACnc : Pt : Ser : QI : Ord : EIA 18396-2 HIV-1 p24 Antigen HIV 1 P24 Ag [Mass/volume] : MCnc : Ser : Qn : EIA 42339-2 HIV-1 p24 Antigen HIV 1 P24 Ag Ser Ql 9821-0 HIV-1 p24 Antigen HIV 1 P24 Ag : ACnc : Pt : CSF : Qn 16979-7 HIV-1 p24 Antigen

Report Type Test Type Source Result Laboratory report Laboratory report Laboratory report HIV-1/2 Type- Differentiating Immunoassay Blood, serum, saliva HIV 1 RNA [Units/volume] (viral load) (Quant bdna) in Plasma by Probe and signal amplification method 4 Positive (undifferentiated HIV), Human Immunodeficiency Virus, Human Immunodeficiency Virus Type 1, Human Immunodeficiency Virus Type 2, Human Immunodeficiency Virus 2 positive with HIV-1 cross reactivity Indeterminate, Human Immunodeficiency Virus 1 Indeterminate, Human Immunodeficiency Virus 2 Indeterminate New event? Data Entry Any of the above, negative, inconclusive, not detected Select: HIV 1 and 2 Ab [Identifier] in Serum or Plasma by Rapid immunoassay 69668-2 Multispot type differentiating HIV 1 and 2 Ab in Serum/Plasma/Blood by Rapid immunoassay 80203-3 Geenius Assay type differentiating HIV 1 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay 68961-2 Geenius Analyte HIV-1 HIV 2 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay 81641-3 Geenius Analyte HIV-2 Positive (undifferentiated HIV), Western Blot, Blood, serum, Human Immunodeficiency Virus, IFA saliva Human Immunodeficiency Virus Type 1, Human Immunodeficiency Virus Type 2 Select: HIV 1 & 2 Ab band pattern [interpretation] : Imp : Pt : Ser : m : IB 43185-8 Differentiating Western blot HIV 1 Ab [Presence] : ACnc : Pt : Body fld : Ord : IB 34592-6 HIV-1 Western Blot HIV 2 IgG Ab [Presence] : ACnc: Pt : Ser : Ord : IB 33806-1 HIV-2 Western Blot HIV 2 Ab [Presence] : ACnc : Pt: Ser : Ord : IB 5225-8 HIV-2 Western Blot HIV 1 Ab: ACnc: Pt: Ser: Ord: IF 14092-1 HIV-1 Immunofluorescence HIV-1 RNA Quantitative NAAT viral load Blood, serum, saliva A numeric value by itself, or a numeric value with a = or a > symbol Numeric value with a less than < symbol indicating an undetectable viral load Any of the above Select: HIV 1 RNA [#/volume] (viral load) : NCnc : Pt : XXX : Probe.amp.tar 25836-8 HIV 1 RNA [Log #/volume] (viral load) : LnCnc : Pt : XXX : Qn : Probe.amp.tar 49890-7 23876-6 HIV-1 viral load (Quantitative) HIV-1 viral load log copies(quantitative) HIV-1 viral load copies(quantitative)

5 New Data Report Type Test Type Source Result event? Entry Detected, Trace, Positive HIV-1 or HIV-2 Laboratory report Qualitative NAT Blood, serum, saliva Undetectable, t detected, Negative, (DNA or RNA) Indeterminate existing event HIV-1 viral load (detected or Select: HIV 1 RNA [#/volume] (viral load) : NCnc : Pt : XXX : Probe.amp.tar 25836-8 trace)(qualitative) HIV 1 RNA [Log #/volume] (viral load) : LnCnc : Pt : XXX : Qn : HIV-1 viral load (detected or 49890-7 Probe.amp.tar trace)(qualitative) HIV 1 RNA [Units/volume] (viral load) (Quant bdna) in Plasma by HIV-1 viral load (detected or 23876-6 Probe and signal amplification method trace)(qualitative) HIV 1 RNA [Presence] : ACnc : Pt : XXX : Ord : Probe.amp.tar 5018-7 HIV-1 RNA/DNA NAT (Qualitative) Laboratory report HIV 1 DNA [Presence] : ACnc : Pt : Ser/Plas : Probe.amp.tar 30245-5 HIV-1 RNA/DNA NAT (Qualitative) HIV 2 DNA Bld Ql PCR 25841-8 HIV-2 RNA/DNA NAT (Qualitative) HIV 2 DNA [Presence] : ACnc : Pt : XXX : Probe.amp.tar 25842-6 HIV-2 RNA/DNA NAT (Qualitative) CD4 absolute count CD4 percent Blood, serum, saliva Numeric result only Select: Deprecated CD4 cells [#/volume]: NCnc : Pt: XXX : Qn 32515-9 CD4 absolute count Deprecated CD4 cells [/100 Cells] : NFr : Pt: XXX : Qn 32516-7 CD4 percent existing event Laboratory report Culture Blood, serum, saliva Human Immunodeficiency Virus, Human Immunodeficiency Virus Type 1, Human Immunodeficiency Virus Type 2 Select: Virus identified : PrId : Pt : xxx : m : Virus culture 6584-7 Virus culture Microorganism identified : PrId : Pt : xxx : m : Culture 11475-1 Microorganism culture existing event

6 ADDITIONAL NOTES: Incident case: A newly reported individual living in Massachusetts, reported within the calendar year, with a diagnosis date within that calendar year Prevalent case: A newly reported individual living in Massachusetts, reported within the calendar year, with a diagnosis date outside of that calendar year Opportunistic infections: Bacterial infection, multiple or recurrent (including Salmonella septicemia) Candidiasis of the lung Candidiasis, Esophogeal Cervical cancer Coccidioidomycosis Cryptococcosis Cryptosporidiosis Cytomegalovirus disease Cytomegalovirus retinitis HIV encephalopathy Herpes simplex Histoplasmosis Isosporiasis Kaposi s sarcoma Lymphoid interstitial pneumonitis Lymphoma, Burkitt s Lymphoma, immunoblastic Lymphoma, primary in brain Mycobacterium avium complex M. Tuberculosis, pulmonary M. Tuberculosis, disseminated Mycobacterium, other species Pneumocystis pneumonia (PCP) Pneumonia (any organism), recurrent Progressive leukoencephalopathy Salmonella septicemia Toxoplasmosis of brain HIV Wasting Syndrome